Numida meleagris isolate 19003 breed g44 Domestic line chromosome 17, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007830.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
myosin heavy chain, skeletal muscle, adult-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
myosin heavy chain, skeletal muscle, adult
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein SCO1 homolog, mitochondrial, transcript variant X2
similar to RNA sequence (same species):INSD:GBYG01006557.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 161 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein SCO1 homolog, mitochondrial, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 161 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 134 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
ADP-ribose/CDP-alcohol diphosphatase, manganese dependent
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
manganese-dependent ADP-ribose/CDP-alcohol diphosphatase
transmembrane protein 220, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane protein 220, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 220, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane protein 220, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 220, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane protein 220, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
mitogen-activated protein kinase kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitogen-activated protein kinase kinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
mitogen-activated protein kinase kinase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
mitogen-activated protein kinase kinase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 4 isoform X1
dual specificity mitogen-activated protein kinase kinase 4 isoform X3
dual specificity mitogen-activated protein kinase kinase 4 isoform X2
dual specificity mitogen-activated protein kinase kinase 4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
dynein axonemal heavy chain 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
dynein axonemal heavy chain 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dynein heavy chain 9, axonemal isoform X1
dynein heavy chain 9, axonemal isoform X2
dynein axonemal heavy chain 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
dynein heavy chain 9, axonemal isoform X3
dynein axonemal heavy chain 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
dynein heavy chain 9, axonemal isoform X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoinositide interacting regulator of transient receptor potential channels, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoinositide interacting regulator of transient receptor potential channels, transcript variant X3
phosphoinositide interacting regulator of transient receptor potential channels, transcript variant X2
phosphoinositide-interacting protein isoform X2
phosphoinositide-interacting protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nudE neurodevelopment protein 1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
nudE neurodevelopment protein 1 like 1, transcript variant X4
nudE neurodevelopment protein 1 like 1, transcript variant X1
nudE neurodevelopment protein 1 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
nudE neurodevelopment protein 1 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nuclear distribution protein nudE-like 1 isoform X2
nuclear distribution protein nudE-like 1 isoform X4
nuclear distribution protein nudE-like 1 isoform X1
nuclear distribution protein nudE-like 1 isoform X3
myosin heavy chain 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
myosin heavy chain 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
myosin heavy chain 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coiled-coil domain-containing protein 42
uncharacterized protein C16orf45-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein C16orf45-like, transcript variant X4
uncharacterized protein C16orf45-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C16orf45-like, transcript variant X3
uncharacterized protein C16orf45 homolog isoform X1
uncharacterized protein C16orf45-like isoform X2
uncharacterized protein C16orf45-like isoform X3
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphoinositide 3-kinase regulatory subunit 6 isoform X2
phosphoinositide 3-kinase regulatory subunit 6 isoform X1
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X4
phosphoinositide 3-kinase regulatory subunit 6 isoform X3
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X6
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X2
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X4
phosphoinositide 3-kinase regulatory subunit 5 isoform X3
phosphoinositide 3-kinase regulatory subunit 5 isoform X2
phosphoinositide 3-kinase regulatory subunit 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
cilia and flagella associated protein 52
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
cilia- and flagella-associated protein 52
ubiquitin specific peptidase 43, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ubiquitin specific peptidase 43, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ubiquitin specific peptidase 43, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ubiquitin specific peptidase 43, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ubiquitin specific peptidase 43, transcript variant X8
ubiquitin specific peptidase 43, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 43 isoform X2
ubiquitin carboxyl-terminal hydrolase 43 isoform X3
ubiquitin carboxyl-terminal hydrolase 43 isoform X1
ubiquitin carboxyl-terminal hydrolase 43 isoform X6
ubiquitin carboxyl-terminal hydrolase 43 isoform X7
ubiquitin specific peptidase 43, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ubiquitin specific peptidase 43, transcript variant X4
ubiquitin specific peptidase 43, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 43 isoform X4
ubiquitin carboxyl-terminal hydrolase 43 isoform X5
Rho GTPase activating protein 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho GTPase activating protein 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho GTPase-activating protein 44 isoform X2
rho GTPase-activating protein 44 isoform X1
Rho GTPase activating protein 44, transcript variant X2
F-box/WD repeat-containing protein 10-like
Golgi apparatus membrane protein TVP23 homolog B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
TANK-binding kinase 1-binding protein 1-like
heparan sulfate glucosamine 3-O-sulfotransferase 3B1-like
similar to RNA sequence (same species):INSD:GBYG01024502.1
similar to RNA sequence (same species):INSD:GBYG01024505.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 475 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 143 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
protoheme IX farnesyltransferase, mitochondrial, transcript variant X2
protoheme IX farnesyltransferase, mitochondrial, transcript variant X1
protoheme IX farnesyltransferase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
protoheme IX farnesyltransferase, mitochondrial isoform X1
protoheme IX farnesyltransferase, mitochondrial isoform X2
heparan sulfate-glucosamine 3-sulfotransferase 3A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 3A1
uncharacterized LOC110407401, transcript variant X2
uncharacterized LOC110407401, transcript variant X3
uncharacterized LOC110407401, transcript variant X1
uncharacterized LOC110407439, transcript variant X3
uncharacterized LOC110407439, transcript variant X2
uncharacterized LOC110407439, transcript variant X1
meteorin like, glial cell differentiation regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fructosamine 3 kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fructosamine 3 kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ketosamine-3-kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ketosamine-3-kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
WD repeat domain 45B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
WD repeat domain 45B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
WD repeat domain 45B, transcript variant X3
WD repeat domain phosphoinositide-interacting protein 3 isoform X2
WD repeat domain phosphoinositide-interacting protein 3 isoform X4
WD repeat domain phosphoinositide-interacting protein 3 isoform X3
WD repeat domain 45B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
WD repeat domain phosphoinositide-interacting protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
chromosome 17 C17orf62 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
chromosome 17 C17orf62 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein C17orf62 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
2-oxoglutarate and iron dependent oxygenase domain containing 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3
urotensin-2 receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
urotensin-2 receptor-like, transcript variant X2
uncharacterized LOC110407425, transcript variant X2
uncharacterized LOC110407425, transcript variant X4
uncharacterized LOC110407425, transcript variant X1
uncharacterized LOC110407425, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC110407425 isoform X2
uncharacterized protein LOC110407425 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
trinucleotide repeat containing 6C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
trinucleotide repeat containing 6C, transcript variant X4
trinucleotide repeat containing 6C, transcript variant X2
trinucleotide repeat containing 6C, transcript variant X1
trinucleotide repeat containing 6C, transcript variant X5
trinucleotide repeat-containing gene 6C protein isoform X1
trinucleotide repeat-containing gene 6C protein isoform X4
trinucleotide repeat-containing gene 6C protein isoform X5
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat containing 6C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
trinucleotide repeat containing 6C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein isoform X6
trinucleotide repeat-containing gene 6C protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110407130, transcript variant X2
uncharacterized LOC110407130, transcript variant X3
uncharacterized LOC110407130, transcript variant X1
SEC14 like lipid binding 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SEC14 like lipid binding 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110407129, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110407129, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X2
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X1
major facilitator superfamily domain containing 11, transcript variant X2
major facilitator superfamily domain containing 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
major facilitator superfamily domain containing 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
major facilitator superfamily domain containing 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
serine and arginine rich splicing factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine and arginine rich splicing factor 2, transcript variant X2
serine and arginine rich splicing factor 2, transcript variant X4
serine and arginine rich splicing factor 2, transcript variant X6
serine and arginine rich splicing factor 2, transcript variant X3
serine and arginine rich splicing factor 2, transcript variant X7
serine and arginine rich splicing factor 2, transcript variant X5
serine and arginine rich splicing factor 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
arginine demethylase and lysine hydroxylase
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6
matrix remodeling associated 7, transcript variant X1
matrix remodeling associated 7, transcript variant X3
matrix remodeling associated 7, transcript variant X2
matrix-remodeling-associated protein 7 isoform X1
matrix-remodeling-associated protein 7 isoform X2
matrix-remodeling-associated protein 7 isoform X3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 isoform X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2, transcript variant X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 isoform X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
rhomboid 5 homolog 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
rhomboid 5 homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
rhomboid 5 homolog 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 O, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X2
ubiquitin conjugating enzyme E2 O, transcript variant X1
ubiquitin conjugating enzyme E2 O, transcript variant X3
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X1
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X4
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X5
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X1
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X9
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X6
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X1
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X2
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X3
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X7
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X4
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ring finger protein 157, transcript variant X9
ring finger protein 157, transcript variant X1
ring finger protein 157, transcript variant X3
ring finger protein 157, transcript variant X6
ring finger protein 157, transcript variant X2
ring finger protein 157, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ring finger protein 157, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 157, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ring finger protein 157, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
exocyst complex component 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
exocyst complex component 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X4
exocyst complex component 7, transcript variant X5
exocyst complex component 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
exocyst complex component 7, transcript variant X7
exocyst complex component 7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
signal recognition particle subunit SRP68
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cyclin dependent kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin dependent kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TEN1, CST complex subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TEN1, CST complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TEN1, CST complex subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TEN1, CST complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
acyl-CoA oxidase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
acyl-CoA oxidase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
peroxisomal acyl-coenzyme A oxidase 1 isoform X2
peroxisomal acyl-coenzyme A oxidase 1 isoform X1
Fas binding factor 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Fas binding factor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Fas binding factor 1, transcript variant X10
Fas binding factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Fas binding factor 1, transcript variant X2
Fas binding factor 1, transcript variant X4
Fas binding factor 1, transcript variant X1
Fas binding factor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Fas binding factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Fas binding factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
39S ribosomal protein L38, mitochondrial
tripartite motif containing 65, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tripartite motif containing 65, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
unkempt family zinc finger, transcript variant X3
unkempt family zinc finger, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
unkempt family zinc finger, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
unkempt family zinc finger, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
unkempt family zinc finger, transcript variant X1
unkempt family zinc finger, transcript variant X2
RING finger protein unkempt homolog isoform X6
RING finger protein unkempt homolog isoform X3
RING finger protein unkempt homolog isoform X2
RING finger protein unkempt homolog isoform X5
RING finger protein unkempt homolog isoform X4
RING finger protein unkempt homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 221 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110407194, transcript variant X2
uncharacterized LOC110407194, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110407194, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC110407194 isoform X2
uncharacterized protein LOC110407194 isoform X3
uncharacterized protein LOC110407194 isoform X1
uncharacterized LOC110407194, transcript variant X5
uncharacterized LOC110407194, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
integrin subunit beta 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
integrin subunit beta 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
integrin subunit beta 4, transcript variant X5
integrin subunit beta 4, transcript variant X7
integrin subunit beta 4, transcript variant X6
integrin subunit beta 4, transcript variant X2
integrin subunit beta 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SAP30 binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SAP30 binding protein, transcript variant X1
RecQ like helicase 5, transcript variant X1
ATP-dependent DNA helicase Q5 isoform X1
RecQ like helicase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RecQ like helicase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ATP-dependent DNA helicase Q5 isoform X2
small integral membrane protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
small integral membrane protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
casein kinase 1 delta, transcript variant X3
casein kinase 1 delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
casein kinase 1 delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
coiled-coil domain containing 57, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain containing 57, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
coiled-coil domain containing 57, transcript variant X4
coiled-coil domain containing 57, transcript variant X5
coiled-coil domain containing 57, transcript variant X2
coiled-coil domain-containing protein 57 isoform X1
coiled-coil domain-containing protein 57 isoform X3
coiled-coil domain-containing protein 57 isoform X2
coiled-coil domain-containing protein 57 isoform X4
coiled-coil domain-containing protein 57 isoform X5
dihydrouridine synthase 1 like, transcript variant X1
dihydrouridine synthase 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like isoform X1
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like isoform X2
G protein pathway suppressor 1, transcript variant X2
G protein pathway suppressor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
G protein pathway suppressor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
G protein pathway suppressor 1, transcript variant X4
COP9 signalosome complex subunit 1 isoform X2
COP9 signalosome complex subunit 1 isoform X3
COP9 signalosome complex subunit 1 isoform X1
dicarbonyl and L-xylulose reductase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dicarbonyl and L-xylulose reductase, transcript variant X2
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3), transcript variant X2
ras-related C3 botulinum toxin substrate 3 isoform X1
ras-related C3 botulinum toxin substrate 3 isoform X2
leucine rich repeat containing 45, transcript variant X4
leucine rich repeat containing 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
leucine rich repeat containing 45, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
leucine rich repeat containing 45, transcript variant X2
leucine-rich repeat-containing protein 45
centromere protein X, transcript variant X5
centromere protein X, transcript variant X6
centromere protein X, transcript variant X1
centromere protein X, transcript variant X2
centromere protein X, transcript variant X3
centromere protein X, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ASPSCR1, UBX domain containing tether for SLC2A4, transcript variant X1
ASPSCR1, UBX domain containing tether for SLC2A4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
tether containing UBX domain for GLUT4 isoform X1
tether containing UBX domain for GLUT4 isoform X2
ASPSCR1, UBX domain containing tether for SLC2A4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
NOTUM, palmitoleoyl-protein carboxylesterase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
NOTUM, palmitoleoyl-protein carboxylesterase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
palmitoleoyl-protein carboxylesterase NOTUM isoform X1
palmitoleoyl-protein carboxylesterase NOTUM isoform X2
myeloid associated differentiation marker like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myeloid-associated differentiation marker-like protein 2
pyrroline-5-carboxylate reductase 1, transcript variant X2
pyrroline-5-carboxylate reductase 1, transcript variant X1
pyrroline-5-carboxylate reductase 1, mitochondrial isoform X1
pyrroline-5-carboxylate reductase 1, mitochondrial isoform X2
MAF bZIP transcription factor G, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
MAF bZIP transcription factor G, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
NAD-dependent protein deacetylase sirtuin-7
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X1
ethanolamine-phosphate cytidylyltransferase isoform X2
ethanolamine-phosphate cytidylyltransferase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Rho GDP dissociation inhibitor alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Rho GDP dissociation inhibitor alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
MAPK regulated corepressor interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
MAPK regulated corepressor interacting protein 1, transcript variant X1
mapk-regulated corepressor-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01014551.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 88 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
39S ribosomal protein L12, mitochondrial
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X2
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X1
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X2
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X1
ADP ribosylation factor like GTPase 16, transcript variant X2
ADP ribosylation factor like GTPase 16, transcript variant X3
ADP ribosylation factor like GTPase 16, transcript variant X4
ADP ribosylation factor like GTPase 16, transcript variant X6
ADP ribosylation factor like GTPase 16, transcript variant X1
ADP ribosylation factor like GTPase 16, transcript variant X5
ADP ribosylation factor like GTPase 16, transcript variant X7
ADP ribosylation factor like GTPase 16, transcript variant X8
ADP ribosylation factor like GTPase 16, transcript variant X9
ADP-ribosylation factor-like protein 16 isoform X2
ADP-ribosylation factor-like protein 16 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
probable low-specificity L-threonine aldolase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylglycerophosphate synthase 1, transcript variant X2
phosphatidylglycerophosphate synthase 1, transcript variant X1
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial isoform X1
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin specific peptidase 36, transcript variant X2
ubiquitin specific peptidase 36, transcript variant X1
ubiquitin specific peptidase 36, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ubiquitin specific peptidase 36, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 36 isoform X2
ubiquitin carboxyl-terminal hydrolase 36 isoform X1
ubiquitin carboxyl-terminal hydrolase 36 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
calcium activated nucleotidase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
calcium activated nucleotidase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
soluble calcium-activated nucleotidase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cytosolic endo-beta-N-acetylglucosaminidase
RNA binding protein, fox-1 homolog 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RNA binding protein, fox-1 homolog 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
RNA binding protein, fox-1 homolog 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA binding protein, fox-1 homolog 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RNA binding protein, fox-1 homolog 3, transcript variant X1
RNA binding protein, fox-1 homolog 3, transcript variant X6
RNA binding protein, fox-1 homolog 3, transcript variant X7
RNA binding protein fox-1 homolog 3 isoform X2
RNA binding protein fox-1 homolog 3 isoform X1
RNA binding protein fox-1 homolog 3 isoform X6
RNA binding protein fox-1 homolog 3 isoform X3
RNA binding protein fox-1 homolog 3 isoform X4
RNA binding protein fox-1 homolog 3 isoform X5
RNA binding protein, fox-1 homolog 3, transcript variant X3
RNA binding protein, fox-1 homolog 3, transcript variant X4
ectonucleotide pyrophosphatase/phosphodiesterase 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ectonucleotide pyrophosphatase/phosphodiesterase family member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
similar to RNA sequence (same species):INSD:GBYG01019705.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 182 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 113 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
TBC1 domain family member 16, transcript variant X9
TBC1 domain family member 16, transcript variant X8
TBC1 domain family member 16, transcript variant X7
TBC1 domain family member 16, transcript variant X6
TBC1 domain family member 16, transcript variant X1
TBC1 domain family member 16, transcript variant X5
TBC1 domain family member 16, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TBC1 domain family member 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TBC1 domain family member 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
coiled-coil domain containing 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coiled-coil domain containing 40, transcript variant X1
coiled-coil domain-containing protein 40
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysosomal alpha-glucosidase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: N-sulphoglucosamine sulphohydrolase
solute carrier family 26 member 11, transcript variant X1
solute carrier family 26 member 11, transcript variant X2
solute carrier family 26 member 11, transcript variant X3
sodium-independent sulfate anion transporter isoform X1
sodium-independent sulfate anion transporter isoform X2
sodium-independent sulfate anion transporter isoform X3
solute carrier family 26 member 11, transcript variant X4
sodium-independent sulfate anion transporter isoform X4
ring finger protein 213, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF213 isoform X2
ring finger protein 213, transcript variant X1
E3 ubiquitin-protein ligase RNF213 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
regulatory associated protein of MTOR complex 1, transcript variant X1
regulatory associated protein of MTOR complex 1, transcript variant X2
regulatory associated protein of MTOR complex 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
regulatory-associated protein of mTOR isoform X1
regulatory-associated protein of mTOR isoform X2
regulatory-associated protein of mTOR isoform X3
BAI1 associated protein 2, transcript variant X4
similar to RNA sequence (same species):INSD:GBYG01007273.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
BAI1 associated protein 2, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
BAI1 associated protein 2, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 72 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X1
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X5
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X4
BAI1 associated protein 2, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
BAI1 associated protein 2, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BAI1 associated protein 2, transcript variant X6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 86 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X2
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X3
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X6
apoptosis associated tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
apoptosis associated tyrosine kinase, transcript variant X1
apoptosis associated tyrosine kinase, transcript variant X3
serine/threonine-protein kinase LMTK1 isoform X2
serine/threonine-protein kinase LMTK1 isoform X1
serine/threonine-protein kinase LMTK1 isoform X3
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2-like
centrosomal protein 131, transcript variant X2
centrosomal protein 131, transcript variant X1
centrosomal protein 131, transcript variant X3
centrosomal protein of 131 kDa isoform X2
centrosomal protein of 131 kDa isoform X1
centrosomal protein of 131 kDa isoform X3
centrosomal protein 131, transcript variant X4
centrosomal protein of 131 kDa isoform X4
TEPSIN, adaptor related protein complex 4 accessory protein
NADH:ubiquinone oxidoreductase complex assembly factor 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8
solute carrier family 38 member 10, transcript variant X1
solute carrier family 38 member 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 38 member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
putative sodium-coupled neutral amino acid transporter 10 isoform X3
putative sodium-coupled neutral amino acid transporter 10 isoform X2
putative sodium-coupled neutral amino acid transporter 10 isoform X1
BAH domain and coiled-coil containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
BAH domain and coiled-coil containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
BAH domain and coiled-coil containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
BAH domain and coiled-coil containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
BAH and coiled-coil domain-containing protein 1 isoform X1
BAH and coiled-coil domain-containing protein 1 isoform X4
BAH and coiled-coil domain-containing protein 1 isoform X2
BAH and coiled-coil domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 569 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 569 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
fascin actin-bundling protein 2, retinal, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fascin actin-bundling protein 2, retinal, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Fanconi anemia core complex associated protein 100, transcript variant X2
Fanconi anemia core complex associated protein 100, transcript variant X1
Fanconi anemia core complex-associated protein 100 isoform X1
Fanconi anemia core complex-associated protein 100 isoform X2
Fanconi anemia core complex associated protein 100, transcript variant X3
NPL4 homolog, ubiquitin recognition factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nuclear protein localization protein 4 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
oxidoreductase-like domain-containing protein 1
coiled-coil domain-containing protein 137
G protein-coupled receptor class C group 5 member C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
G protein-coupled receptor class C group 5 member C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
G protein-coupled receptor class C group 5 member C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
G-protein coupled receptor family C group 5 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BTB domain containing 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BTB/POZ domain-containing protein 17 isoform X2
BTB domain containing 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BTB/POZ domain-containing protein 17 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
tweety family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tweety family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ribosomal protein L38, transcript variant X1
ribosomal protein L38, transcript variant X2
sidekick cell adhesion molecule 2, transcript variant X1
sidekick cell adhesion molecule 2, transcript variant X2
sidekick cell adhesion molecule 2, transcript variant X3
sidekick cell adhesion molecule 2, transcript variant X4
CDC42 effector protein 4, transcript variant X1
CDC42 effector protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
CDC42 effector protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
CDC42 effector protein 4, transcript variant X3
cleavage and polyadenylation specificity factor subunit 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: cleavage and polyadenylation specificity factor subunit 4-like
chromosome 17 C17orf80 homolog, transcript variant X2
chromosome 17 C17orf80 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized protein C17orf80 homolog isoform X2
uncharacterized protein C17orf80 homolog isoform X1
family with sequence similarity 104 member A, transcript variant X1
family with sequence similarity 104 member A, transcript variant X3
family with sequence similarity 104 member A, transcript variant X2
family with sequence similarity 104 member A, transcript variant X4
conserved oligomeric Golgi complex subunit 1
solute carrier family 39 member 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 39 member 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
solute carrier family 39 member 11, transcript variant X1
solute carrier family 39 member 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110407325, transcript variant X2
uncharacterized LOC110407325, transcript variant X1
uncharacterized LOC110407525, transcript variant X2
uncharacterized LOC110407525, transcript variant X1
uncharacterized LOC110407525, transcript variant X3
potassium voltage-gated channel subfamily J member 2, transcript variant X7
potassium voltage-gated channel subfamily J member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X9
potassium voltage-gated channel subfamily J member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 16, transcript variant X2
mitogen-activated protein kinase kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
mitogen-activated protein kinase kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 6 isoform X2
dual specificity mitogen-activated protein kinase kinase 6 isoform X1
uncharacterized LOC110407252, transcript variant X1
uncharacterized LOC110407252, transcript variant X2
uncharacterized LOC110407252, transcript variant X3
uncharacterized LOC110407252, transcript variant X4
ATP binding cassette subfamily A member 5, transcript variant X1
ATP binding cassette subfamily A member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ATP binding cassette subfamily A member 5, transcript variant X2
ATP-binding cassette sub-family A member 5 isoform X1
ATP-binding cassette sub-family A member 5 isoform X2
ATP-binding cassette sub-family A member 9-like, transcript variant X2
ATP-binding cassette sub-family A member 9-like, transcript variant X3
ATP-binding cassette sub-family A member 9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATP-binding cassette sub-family A member 9-like isoform X1
ATP-binding cassette sub-family A member 6-like isoform X2
ATP-binding cassette sub-family A member 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
FAM20A, golgi associated secretory pathway pseudokinase
similar to RNA sequence (same species):INSD:GBYG01021914.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 42 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 42 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
protein kinase cAMP-dependent type I regulatory subunit alpha
cAMP-dependent protein kinase type I-alpha regulatory subunit
WD repeat domain, phosphoinositide interacting 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
WD repeat domain phosphoinositide-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 16 member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 16 member 6, transcript variant X1
monocarboxylate transporter 7 isoform X1
monocarboxylate transporter 7 isoform X2
solute carrier family 16 member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
monocarboxylate transporter 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-13
regulator of G protein signaling 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
regulator of G protein signaling 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 9 isoform X2
regulator of G-protein signaling 9 isoform X1
centrosomal protein 112, transcript variant X1
centrosomal protein of 112 kDa isoform X1
centrosomal protein 112, transcript variant X4
centrosomal protein 112, transcript variant X5
centrosomal protein 112, transcript variant X3
centrosomal protein 112, transcript variant X2
centrosomal protein of 112 kDa isoform X2
uncharacterized LOC110407303, transcript variant X2
uncharacterized LOC110407303, transcript variant X1
protein kinase C alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein kinase C alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC110407229, transcript variant X2
uncharacterized LOC110407229, transcript variant X1
calcium voltage-gated channel auxiliary subunit gamma 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent calcium channel gamma-5 subunit
uncharacterized LOC110407453, transcript variant X2
uncharacterized LOC110407453, transcript variant X3
uncharacterized LOC110407453, transcript variant X4
uncharacterized LOC110407453, transcript variant X1
calcium voltage-gated channel auxiliary subunit gamma 4
voltage-dependent calcium channel gamma-4 subunit
calcium voltage-gated channel auxiliary subunit gamma 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent calcium channel gamma-1 subunit
helicase with zinc finger, transcript variant X5
helicase with zinc finger, transcript variant X4
helicase with zinc finger, transcript variant X3
helicase with zinc finger, transcript variant X1
helicase with zinc finger, transcript variant X6
helicase with zinc finger, transcript variant X2
probable helicase with zinc finger domain isoform X4
probable helicase with zinc finger domain isoform X2
probable helicase with zinc finger domain isoform X3
probable helicase with zinc finger domain isoform X1
probable helicase with zinc finger domain isoform X5
proteasome 26S subunit, non-ATPase 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 12 isoform X1
proteasome 26S subunit, non-ATPase 12, transcript variant X2
26S proteasome non-ATPase regulatory subunit 12 isoform X2
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X5
cytoplasmic phosphatidylinositol transfer protein 1 isoform X1
cytoplasmic phosphatidylinositol transfer protein 1 isoform X3
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X3
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X2
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110407168, transcript variant X2
phosphatidylinositol transfer protein, cytoplasmic 1, transcript variant X6
cytoplasmic phosphatidylinositol transfer protein 1 isoform X2
cytoplasmic phosphatidylinositol transfer protein 1 isoform X4
uncharacterized LOC110407168, transcript variant X3
uncharacterized LOC110407168, transcript variant X1
bromodomain PHD finger transcription factor, transcript variant X3
bromodomain PHD finger transcription factor, transcript variant X6
bromodomain PHD finger transcription factor, transcript variant X10
bromodomain PHD finger transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
bromodomain PHD finger transcription factor, transcript variant X5
bromodomain PHD finger transcription factor, transcript variant X7
bromodomain PHD finger transcription factor, transcript variant X4
bromodomain PHD finger transcription factor, transcript variant X8
bromodomain PHD finger transcription factor, transcript variant X2
nucleosome-remodeling factor subunit BPTF isoform X3
nucleosome-remodeling factor subunit BPTF isoform X6
nucleosome-remodeling factor subunit BPTF isoform X10
nucleosome-remodeling factor subunit BPTF isoform X1
nucleosome-remodeling factor subunit BPTF isoform X5
nucleosome-remodeling factor subunit BPTF isoform X7
nucleosome-remodeling factor subunit BPTF isoform X4
nucleosome-remodeling factor subunit BPTF isoform X8
nucleosome-remodeling factor subunit BPTF isoform X2
bromodomain PHD finger transcription factor, transcript variant X9
bromodomain PHD finger transcription factor, transcript variant X12
nucleosome-remodeling factor subunit BPTF isoform X9
nucleosome-remodeling factor subunit BPTF isoform X12
bromodomain PHD finger transcription factor, transcript variant X11
nucleosome-remodeling factor subunit BPTF isoform X11
chromosome 17 C17orf58 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromosome 17 C17orf58 homolog, transcript variant X2
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
karyopherin subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
karyopherin subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110407279, transcript variant X3
uncharacterized LOC110407279, transcript variant X2
uncharacterized LOC110407279, transcript variant X1
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
E3 ubiquitin-protein ligase SMURF2 isoform X1
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
E3 ubiquitin-protein ligase SMURF2 isoform X2
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
E3 ubiquitin-protein ligase SMURF2 isoform X3
centrosomal protein 95, transcript variant X1
centrosomal protein 95, transcript variant X3
centrosomal protein 95, transcript variant X2
centrosomal protein of 95 kDa isoform X1
centrosomal protein of 95 kDa isoform X2
DEAD-box helicase 5, transcript variant X2
DEAD-box helicase 5, transcript variant X1
probable ATP-dependent RNA helicase DDX5 isoform X1
probable ATP-dependent RNA helicase DDX5 isoform X2
DNA polymerase gamma 2, accessory subunit
DNA polymerase subunit gamma-2, mitochondrial
mast cell immunoglobulin like receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X10
platelet and endothelial cell adhesion molecule 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
platelet and endothelial cell adhesion molecule 1, transcript variant X1
platelet and endothelial cell adhesion molecule 1, transcript variant X2
platelet and endothelial cell adhesion molecule 1, transcript variant X3
platelet and endothelial cell adhesion molecule 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X5
platelet and endothelial cell adhesion molecule 1, transcript variant X7
platelet and endothelial cell adhesion molecule 1, transcript variant X9
platelet and endothelial cell adhesion molecule 1, transcript variant X12
platelet and endothelial cell adhesion molecule 1, transcript variant X4
platelet and endothelial cell adhesion molecule 1, transcript variant X8
platelet and endothelial cell adhesion molecule 1, transcript variant X11
platelet and endothelial cell adhesion molecule 1, transcript variant X13
platelet and endothelial cell adhesion molecule 1, transcript variant X14
platelet endothelial cell adhesion molecule isoform X1
platelet endothelial cell adhesion molecule isoform X3
platelet endothelial cell adhesion molecule isoform X5
platelet endothelial cell adhesion molecule isoform X9
platelet endothelial cell adhesion molecule isoform X4
platelet endothelial cell adhesion molecule isoform X8
platelet endothelial cell adhesion molecule isoform X13
platelet endothelial cell adhesion molecule isoform X2
platelet endothelial cell adhesion molecule isoform X6
platelet endothelial cell adhesion molecule isoform X7
platelet endothelial cell adhesion molecule isoform X12
platelet endothelial cell adhesion molecule isoform X11
platelet endothelial cell adhesion molecule isoform X14
platelet endothelial cell adhesion molecule isoform X15
platelet endothelial cell adhesion molecule isoform X10
testis expressed 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
testis expressed 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
endoplasmic reticulum to nucleus signaling 1
similar to RNA sequence (same species):INSD:GBYG01029216.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 107 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 69 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
serine/threonine-protein kinase/endoribonuclease IRE1
zinc finger protein 207, transcript variant X2
zinc finger protein 207, transcript variant X3
zinc finger protein 207, transcript variant X1
zinc finger protein 207, transcript variant X5
zinc finger protein 207, transcript variant X6
zinc finger protein 207, transcript variant X4
zinc finger protein 207, transcript variant X7
zinc finger protein 207, transcript variant X9
zinc finger protein 207, transcript variant X8
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X4
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X6
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X2
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X7
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X3
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X5
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X1
chromosome 17 C17orf75 homolog, transcript variant X2
chromosome 17 C17orf75 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ras homolog family member T1, transcript variant X4
ras homolog family member T1, transcript variant X1
ras homolog family member T1, transcript variant X6
ras homolog family member T1, transcript variant X3
ras homolog family member T1, transcript variant X2
ras homolog family member T1, transcript variant X5
ArfGAP with dual PH domains 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ArfGAP with dual PH domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
arf-GAP with dual PH domain-containing protein 2 isoform X1
arf-GAP with dual PH domain-containing protein 2 isoform X2
ATPase family, AAA domain containing 5, transcript variant X2
ATPase family, AAA domain containing 5, transcript variant X1
ATPase family AAA domain-containing protein 5 isoform X2
ATPase family AAA domain-containing protein 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
SUZ12 polycomb repressive complex 2 subunit
UTP6, small subunit processome component
U3 small nucleolar RNA-associated protein 6 homolog
coordinator of PRMT5 and differentiation stimulator, transcript variant X1
coordinator of PRMT5 and differentiation stimulator, transcript variant X2
coordinator of PRMT5 and differentiation stimulator
coordinator of PRMT5 and differentiation stimulator, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC110407123, transcript variant X2
coordinator of PRMT5 and differentiation stimulator, transcript variant X5
coordinator of PRMT5 and differentiation stimulator, transcript variant X3
uncharacterized LOC110407123, transcript variant X1
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RAB11 family interacting protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
RAB11 family interacting protein 4, transcript variant X1
RAB11 family interacting protein 4, transcript variant X5
RAB11 family interacting protein 4, transcript variant X3
RAB11 family interacting protein 4, transcript variant X4
rab11 family-interacting protein 4 isoform X2
rab11 family-interacting protein 4 isoform X1
rab11 family-interacting protein 4 isoform X5
rab11 family-interacting protein 4 isoform X3
rab11 family-interacting protein 4 isoform X4
serine carboxypeptidase 1, transcript variant X2
serine carboxypeptidase 1, transcript variant X1
serine carboxypeptidase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
serine carboxypeptidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
retinoid-inducible serine carboxypeptidase isoform X1
retinoid-inducible serine carboxypeptidase isoform X3
retinoid-inducible serine carboxypeptidase isoform X2
serine carboxypeptidase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
diacylglycerol kinase epsilon, transcript variant X3
diacylglycerol kinase epsilon isoform X3
diacylglycerol kinase epsilon, transcript variant X2
diacylglycerol kinase epsilon, transcript variant X1
diacylglycerol kinase epsilon isoform X2
diacylglycerol kinase epsilon isoform X1
diacylglycerol kinase epsilon, transcript variant X4
diacylglycerol kinase epsilon isoform X4
uncharacterized protein C17orf67 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and fibronectin type III domain containing 1
ankyrin repeat and fibronectin type-III domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylcholine transfer protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
phosphatidylcholine transfer protein, transcript variant X2
phosphatidylcholine transfer protein isoform X1
phosphatidylcholine transfer protein isoform X2
transmembrane protein 100, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 100, transcript variant X1
transmembrane protein 100, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
monocyte to macrophage differentiation associated, transcript variant X3
monocyte to macrophage differentiation associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocyte to macrophage differentiation factor isoform X3
monocyte to macrophage differentiation factor isoform X1
monocyte to macrophage differentiation associated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
monocyte to macrophage differentiation factor isoform X2
uncharacterized LOC110407211, transcript variant X2
uncharacterized LOC110407211, transcript variant X3
uncharacterized LOC110407211, transcript variant X4
uncharacterized LOC110407211, transcript variant X9
uncharacterized LOC110407211, transcript variant X1
uncharacterized LOC110407211, transcript variant X5
uncharacterized LOC110407211, transcript variant X7
uncharacterized LOC110407211, transcript variant X10
uncharacterized LOC110407211, transcript variant X11
uncharacterized LOC110407211, transcript variant X14
uncharacterized LOC110407211, transcript variant X8
uncharacterized LOC110407211, transcript variant X6
uncharacterized LOC110407211, transcript variant X12
uncharacterized LOC110407211, transcript variant X13
syntaxin binding protein 4, transcript variant X2
syntaxin binding protein 4, transcript variant X1
syntaxin binding protein 4, transcript variant X3
syntaxin binding protein 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
syntaxin binding protein 4, transcript variant X4
syntaxin binding protein 4, transcript variant X5
cytochrome c oxidase assembly protein COX11, mitochondrial
similar to RNA sequence (same species):INSD:GBYG01017154.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 276 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 261 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
target of myb1 like 1 membrane trafficking protein, transcript variant X2
target of myb1 like 1 membrane trafficking protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
target of myb1 like 1 membrane trafficking protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
target of myb1 like 1 membrane trafficking protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
target of myb1 like 1 membrane trafficking protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110407384, transcript variant X1
uncharacterized LOC110407384, transcript variant X2
carbonic anhydrase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
carbonic anhydrase 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
carbonic anhydrase 10, transcript variant X3
carbonic anhydrase 10, transcript variant X4
UTP18, small subunit processome component
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
LOW QUALITY PROTEIN: U3 small nucleolar RNA-associated protein 18 homolog
mbt domain containing 1, transcript variant X2
mbt domain containing 1, transcript variant X1
mbt domain containing 1, transcript variant X4
mbt domain containing 1, transcript variant X5
mbt domain containing 1, transcript variant X6
mbt domain containing 1, transcript variant X7
mbt domain containing 1, transcript variant X8
mbt domain containing 1, transcript variant X3
MBT domain-containing protein 1 isoform X1
MBT domain-containing protein 1 isoform X2
MBT domain-containing protein 1 isoform X3
MBT domain-containing protein 1 isoform X4
MBT domain-containing protein 1 isoform X5
MBT domain-containing protein 1 isoform X6
NME/NM23 nucleoside diphosphate kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
NME/NM23 nucleoside diphosphate kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
NME/NM23 nucleoside diphosphate kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nucleoside diphosphate kinase-like isoform X1
nucleoside diphosphate kinase-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nucleoside diphosphate kinase-like, transcript variant X9
UPF0317 protein KRH_21160-like isoform X3
uncharacterized protein LOC110407151 isoform X2
sperm associated antigen 9, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01030127.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 178 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sperm associated antigen 9, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 178 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
sperm associated antigen 9, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 178 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sperm associated antigen 9, transcript variant X3
sperm associated antigen 9, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 178 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 153 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
C-Jun-amino-terminal kinase-interacting protein 4 isoform X1
C-Jun-amino-terminal kinase-interacting protein 4 isoform X3
C-Jun-amino-terminal kinase-interacting protein 4 isoform X2
C-Jun-amino-terminal kinase-interacting protein 4 isoform X4
C-Jun-amino-terminal kinase-interacting protein 4 isoform X5
transducer of ERBB2, 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transducer of ERBB2, 1, transcript variant X1
transducer of ERBB2, 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2
uncharacterized LOC110407472, transcript variant X1
uncharacterized LOC110407472, transcript variant X2
ankyrin repeat domain 40, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ankyrin repeat domain 40, transcript variant X2
ankyrin repeat domain-containing protein 40-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ankyrin repeat domain-containing protein 40 isoform X3
ankyrin repeat domain-containing protein 40 isoform X2
LUC7 like 3 pre-mRNA splicing factor, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01025260.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 515 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
LUC7 like 3 pre-mRNA splicing factor, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 515 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
LUC7 like 3 pre-mRNA splicing factor, transcript variant X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 99 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
LUC7 like 3 pre-mRNA splicing factor, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 515 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
LUC7 like 3 pre-mRNA splicing factor, transcript variant X5
ankyrin repeat domain 40, transcript variant X1
ankyrin repeat domain 40, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ankyrin repeat domain-containing protein 40 isoform X1
ankyrin repeat domain-containing protein 40 isoform X4
ATP binding cassette subfamily C member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
canalicular multispecific organic anion transporter 2 isoform X1
ATP binding cassette subfamily C member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ATP binding cassette subfamily C member 3, transcript variant X3
canalicular multispecific organic anion transporter 2 isoform X2
ATP binding cassette subfamily C member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
canalicular multispecific organic anion transporter 2 isoform X3
uncharacterized LOC110407489, transcript variant X2
uncharacterized LOC110407489, transcript variant X1
calcium voltage-gated channel subunit alpha1 G, transcript variant X1
calcium voltage-gated channel subunit alpha1 G, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent T-type calcium channel subunit alpha-1G isoform X1
voltage-dependent T-type calcium channel subunit alpha-1G isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
MYCBP associated protein, transcript variant X3
MYCBP associated protein, transcript variant X2
MYCBP associated protein, transcript variant X1
radical S-adenosyl methionine domain containing 1, transcript variant X2
radical S-adenosyl methionine domain containing 1, transcript variant X1
radical S-adenosyl methionine domain-containing protein 1, mitochondrial isoform X2
radical S-adenosyl methionine domain-containing protein 1, mitochondrial isoform X1
acyl-CoA synthetase family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
acyl-CoA synthetase family member 2, transcript variant X1
acyl-CoA synthetase family member 2, transcript variant X3
acyl-CoA synthetase family member 2, transcript variant X2
acyl-CoA synthetase family member 2, transcript variant X5
acyl-CoA synthetase family member 2, mitochondrial isoform X1
acyl-CoA synthetase family member 2, mitochondrial isoform X3
acyl-CoA synthetase family member 2, mitochondrial isoform X2
acyl-CoA synthetase family member 2, mitochondrial isoform X4
leucine rich repeat containing 59, transcript variant X1
leucine rich repeat containing 59, transcript variant X2
leucine-rich repeat-containing protein 59 isoform X1
leucine-rich repeat-containing protein 59 isoform X2
essential meiotic structure-specific endonuclease 1, transcript variant X2
crossover junction endonuclease EME1 isoform X2
essential meiotic structure-specific endonuclease 1, transcript variant X3
essential meiotic structure-specific endonuclease 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
crossover junction endonuclease EME1 isoform X3
crossover junction endonuclease EME1 isoform X1
39S ribosomal protein L27, mitochondrial
xylosyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
xylosyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: CMRF35-like molecule 8
RAB37, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RAB37, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAB37, member RAS oncogene family, transcript variant X4
RAB37, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
SLC9A3 regulator 1, transcript variant X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 isoform X1
SLC9A3 regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 isoform X2
N-acetyltransferase 9 (putative), transcript variant X3
N-acetyltransferase 9 (putative), transcript variant X1
N-acetyltransferase 9 (putative), transcript variant X2
N-acetyltransferase 9 (putative), transcript variant X5
N-acetyltransferase 9 (putative), transcript variant X4
transmembrane protein 104, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane protein 104, transcript variant X1
transmembrane protein 104, transcript variant X3
glutamate ionotropic receptor NMDA type subunit 2C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 2C, transcript variant X4
glutamate ionotropic receptor NMDA type subunit 2C, transcript variant X1
glutamate ionotropic receptor NMDA type subunit 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 2C isoform X2
glutamate receptor ionotropic, NMDA 2C isoform X1
glutamate receptor ionotropic, NMDA 2C isoform X3
ferredoxin reductase, transcript variant X4
ferredoxin reductase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ferredoxin reductase, transcript variant X2
ferredoxin reductase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
NADPH:adrenodoxin oxidoreductase, mitochondrial isoform X4
NADPH:adrenodoxin oxidoreductase, mitochondrial isoform X3
NADPH:adrenodoxin oxidoreductase, mitochondrial isoform X2
NADPH:adrenodoxin oxidoreductase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
HID1 domain containing, transcript variant X2
HID1 domain containing, transcript variant X1
uncharacterized LOC110407447, transcript variant X3
uncharacterized LOC110407447, transcript variant X1
uncharacterized LOC110407447, transcript variant X2
cerebellar degeneration related protein 2 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
cerebellar degeneration-related protein 2-like
mitochondrial ribosomal protein L58, transcript variant X1
mitochondrial ribosomal protein L58, transcript variant X2
mitochondrial ribosomal protein L58, transcript variant X3
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X1
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X2
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X3
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase, H+ transporting, mitochondrial Fo complex subunit D, transcript variant X1
ATP synthase, H+ transporting, mitochondrial Fo complex subunit D, transcript variant X2
potassium channel tetramerization domain containing 2
uncharacterized LOC110407177, transcript variant X16
uncharacterized LOC110407177, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC110407177, transcript variant X18
uncharacterized LOC110407177, transcript variant X5
uncharacterized LOC110407177, transcript variant X11
uncharacterized LOC110407177, transcript variant X4
uncharacterized LOC110407177, transcript variant X15
uncharacterized LOC110407177, transcript variant X13
uncharacterized LOC110407177, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110407177, transcript variant X14
uncharacterized LOC110407177, transcript variant X8
uncharacterized LOC110407177, transcript variant X12
uncharacterized LOC110407177, transcript variant X10
uncharacterized LOC110407177, transcript variant X6
uncharacterized LOC110407177, transcript variant X3
uncharacterized LOC110407177, transcript variant X7
uncharacterized LOC110407177, transcript variant X1
uncharacterized LOC110407177, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
5'(3')-deoxyribonucleotidase, cytosolic type
Jupiter microtubule associated homolog 1
hematological and neurological expressed 1 protein
nuclear pore complex protein Nup85 isoform X1
nuclear pore complex protein Nup85 isoform X2
golgi associated, gamma adaptin ear containing, ARF binding protein 3, transcript variant X2
golgi associated, gamma adaptin ear containing, ARF binding protein 3, transcript variant X1
ADP-ribosylation factor-binding protein GGA3 isoform X2
ADP-ribosylation factor-binding protein GGA3 isoform X1
golgi associated, gamma adaptin ear containing, ARF binding protein 3, transcript variant X3
ADP-ribosylation factor-binding protein GGA3 isoform X3
MIF4G domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
MIF4G domain containing, transcript variant X1
MIF4G domain containing, transcript variant X3
MIF4G domain containing, transcript variant X2
solute carrier family 25 member 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
solute carrier family 25 member 19, transcript variant X1
mitochondrial thiamine pyrophosphate carrier
growth factor receptor bound protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
growth factor receptor bound protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
growth factor receptor bound protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
growth factor receptor bound protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
growth factor receptor bound protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane protein 94, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane protein 94, transcript variant X1
transmembrane protein 94, transcript variant X3
CASK interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X9
CASK interacting protein 2, transcript variant X11
CASK interacting protein 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X1
CASK interacting protein 2, transcript variant X2
CASK interacting protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CASK interacting protein 2, transcript variant X5
CASK interacting protein 2, transcript variant X12
melanin-concentrating hormone receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: melanin-concentrating hormone receptor 1-like
tRNA splicing endonuclease subunit 54, transcript variant X2
tRNA splicing endonuclease subunit 54, transcript variant X1
tRNA splicing endonuclease subunit 54, transcript variant X3
tRNA splicing endonuclease subunit 54, transcript variant X4
tRNA-splicing endonuclease subunit Sen54 isoform X3
tRNA-splicing endonuclease subunit Sen54 isoform X1
tRNA-splicing endonuclease subunit Sen54 isoform X2
tRNA-splicing endonuclease subunit Sen54 isoform X4
LLGL2, scribble cell polarity complex component, transcript variant X4
LLGL2, scribble cell polarity complex component, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
LLGL2, scribble cell polarity complex component, transcript variant X2
LLGL2, scribble cell polarity complex component, transcript variant X3
LLGL2, scribble cell polarity complex component, transcript variant X1
LLGL2, scribble cell polarity complex component, transcript variant X8
lethal(2) giant larvae protein homolog 2 isoform X2
lethal(2) giant larvae protein homolog 2 isoform X4
lethal(2) giant larvae protein homolog 2 isoform X3
lethal(2) giant larvae protein homolog 2 isoform X1
LLGL2, scribble cell polarity complex component, transcript variant X7
LLGL2, scribble cell polarity complex component, transcript variant X6
lethal(2) giant larvae protein homolog 2 isoform X5
lethal(2) giant larvae protein homolog 2 isoform X6